0001213900-23-012598.txt : 20230217
0001213900-23-012598.hdr.sgml : 20230217
20230217083007
ACCESSION NUMBER: 0001213900-23-012598
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kapoor Vishal
CENTRAL INDEX KEY: 0001798946
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39138
FILM NUMBER: 23640394
MAIL ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS, FL 40
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jasper Therapeutics, Inc.
CENTRAL INDEX KEY: 0001788028
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842984849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 6505491400
MAIL ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp
DATE OF NAME CHANGE: 20190912
4
1
ownership.xml
X0306
4
2023-02-16
0
0001788028
Jasper Therapeutics, Inc.
JSPR
0001798946
Kapoor Vishal
C/O JASPER THERAPEUTICS, INC.
2200 BRIDGE PKWY, SUITE 102
REDWOOD CITY
CA
94065
1
0
0
0
Stock Option (right to buy)
1.83
2023-02-16
4
A
0
109383
0.00
A
2033-02-16
Voting Common stock
109383
109383
D
1/3rd of the shares subject to the option shall vest on February 16, 2024, and 1/3rd of the shares subject to the option shall vest on each anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
/s/ Jeet Mahal, as Attorney-in-Fact
2023-02-17